ArticleFrontiers in psychiatry2025

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial.

Marie de Deus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.